Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer ...
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...
Hospitals struggling to attract and retain enough registered nurses at the bedside are implementing alternative strategies to ...
New research from Johns Hopkins Medicine adds to existing evidence that smoking fewer cigarettes does not eliminate ...
Ultra-processed foods (UPFs) are a leading cause of the "chronic disease pandemic" linked to diet, with food firms putting ...
A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 ...
A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...
8h
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...
A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
Wear and tear, injury, certain medical conditions, and age can take a toll on shoulder function. Oftentimes, surgery can be ...
A new study by Phoenix's Barrow Neurological Institute and the University of Calgary has found which injectable treatments showed the most benefit for migraine patients and should be routinely offered ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback